HEALX LTD
Patent Applications and Registrations
Patent applications and USPTO patent grants for HEALX LTD.The latest application filed is for "treatment of fragile x syndrome".
- HEALX LTD - Cambridge GB
- Healx Limited - Cambridge GB
Trademarks
| Patent | Date |
|---|---|
| Treatment Of Fragile X Syndrome App 20220280490 - BROWN; David | 2022-09-08 |
| Tricyclic Dibenzothiazepine Type Compounds For Use In The Therapy Of Cdkl5 Disorder App 20220265676 - Cavalla; David | 2022-08-25 |
| Minocycline For The Treatment Of Pitt-hopkins Syndrome App 20220133752 - BROWN; David | 2022-05-05 |
| Treatment Of Pitt-hopkins Syndrome App 20220133651 - BROWN; David | 2022-05-05 |
| Treatment of fragile X syndrome Grant 10,864,182 - Brown December 15, 2 | 2020-12-15 |
| Tricyclic Dibenzothiazepine Type Compounds For Use In The Therapy Of Cdkl5 Disorder App 20190381065 - Cavalla; David | 2019-12-19 |
| Kit, Composition, And Combination Therapy For Fragile X Syndrome App 20190314309 - Brown; David | 2019-10-17 |
| Treatment Of Fragile X Syndrome App 20190314308 - Brown; David | 2019-10-17 |
| Tricyclic Dibenzothiazepine Type Compounds For Use In The Therapy Of Cdkl5 Disorder App 20180271876 - Cavalla; David | 2018-09-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 